BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6540246)

  • 1. Effects of cis-platinum on embryonal carcinoma cell lines in vitro.
    Oosterhuis JW; Andrews PW; Knowles BB; Damjanov I
    Int J Cancer; 1984 Jul; 34(1):133-9. PubMed ID: 6540246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pluripotent human stem-cell clone isolated from the TERA-2 teratocarcinoma line lacks antigens SSEA-3 and SSEA-4 in vitro, but expresses these antigens when grown as a xenograft tumor.
    Andrews PW; Damjanov I; Simon D; Dignazio M
    Differentiation; 1985; 29(2):127-35. PubMed ID: 2412924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three monoclonal antibodies defining distinct differentiation antigens associated with different high molecular weight polypeptides on the surface of human embryonal carcinoma cells.
    Andrews PW; Banting G; Damjanov I; Arnaud D; Avner P
    Hybridoma; 1984; 3(4):347-61. PubMed ID: 6396197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro.
    Andrews PW
    Dev Biol; 1984 Jun; 103(2):285-93. PubMed ID: 6144603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. cis-diamminedichloroplatinum(ii) resistance in vitro and in vivo in human embryonal carcinoma cells.
    Timmer-Bosscha H; Timmer A; Meijer C; de Vries EG; de Jong B; Oosterhuis JW; Mulder NH
    Cancer Res; 1993 Dec; 53(23):5707-13. PubMed ID: 8242627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of Oct-3/4 expression in embryonal carcinoma cells is associated with induction of cisplatin resistance.
    Mueller T; Mueller LP; Luetzkendorf J; Voigt W; Simon H; Schmoll HJ
    Tumour Biol; 2006; 27(2):71-83. PubMed ID: 16557044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complementation analyses of differentiation-defective embryonal carcinoma cells.
    McCue PA; Gubler ML; Maffei L; Sherman MI
    Dev Biol; 1984 Jun; 103(2):399-408. PubMed ID: 6144604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human teratocarcinomas.
    Andrews PW
    Biochim Biophys Acta; 1988 Aug; 948(1):17-36. PubMed ID: 3293662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD30 and its ligand: possible role in regulation of teratoma stem cells.
    Pera MF; Bennett W; Cerretti DP
    APMIS; 1998 Jan; 106(1):169-72; discussion 173. PubMed ID: 9524575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxicity of plant lectins for mouse embryonal carcinoma cells.
    DrĂ¡ber P; Stanley P
    Somat Cell Mol Genet; 1984 Sep; 10(5):435-43. PubMed ID: 6591443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commitment in a murine embryonal carcinoma cell line during differentiation induced by retinoic acid.
    Campione-Piccardo J; Craig J; Sun JJ; McBurney MW
    Exp Cell Res; 1985 Feb; 156(2):544-52. PubMed ID: 3967691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cultured stem-cells from human testicular teratomas: the nature of human embryonal carcinoma, and its comparison with two types of yolk-sac carcinoma.
    Pera MF; Blasco Lafita MJ; Mills J
    Int J Cancer; 1987 Sep; 40(3):334-43. PubMed ID: 2442105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine embryonal carcinoma cells differentiate in vitro in response to retinol.
    Eglitis MA; Sherman MI
    Exp Cell Res; 1983 Jul; 146(2):289-96. PubMed ID: 6683658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of differentiation in mouse embryonal carcinoma cell lines by coculture with rat glioma cells.
    Allin EP
    Cell Mol Biol; 1984; 30(4):377-84. PubMed ID: 6488239
    [No Abstract]   [Full Text] [Related]  

  • 15. Murine lymphocyte and embryonal carcinoma cell surface antigens recognised by rabbit anti-murine embryonal carcinoma serum.
    Stern PL; Beresford NA; Bell SM; Thompson S
    Exp Cell Biol; 1986; 54(5-6):250-62. PubMed ID: 3803690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast feeder layers inhibit differentiation of retinoic acid-treated embryonal carcinoma cells by increasing the probability of stem cell renewal.
    Rosenstraus MJ; Sterman B; Carr A; Brand L
    Exp Cell Res; 1984 Jun; 152(2):378-89. PubMed ID: 6723794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overt expression of H-2 serotypes on EC cells is not necessary for host rejection.
    Maher LJ; Dove WF
    Immunogenetics; 1984; 19(4):343-7. PubMed ID: 6715024
    [No Abstract]   [Full Text] [Related]  

  • 18. Variant embryonal carcinoma cells lacking SSEA-1 and Forsmann antigens remain developmentally pluripotent.
    Buckalew JJ; Sterman B; Rosenstraus M
    Dev Biol; 1985 Jan; 107(1):134-41. PubMed ID: 2856907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The response of several murine embryonal carcinoma cell lines to stimulation of differentiation by alpha-difluoromethylornithine.
    Schindler J; Kelly M; McCann PP
    J Cell Physiol; 1985 Jan; 122(1):1-6. PubMed ID: 3917438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of teratocarcinoma F9 cell differentiation with cis-diammine dichloroplatinum(II) (CDDP).
    Doi T; Sumi T; Nishina Y; Kosaka M; Iwai SA; Sakuda M; Nishimune Y
    Cancer Lett; 1995 Jan; 88(1):81-6. PubMed ID: 7850777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.